Europe Rivaroxaban Market Report 2016

September 2016 | 127 pages | ID: E6AEA42FEECEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Rivaroxaban

Revenue, means the sales value of Rivaroxaban

This report studies sales (consumption) of Rivaroxaban in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Rivaroxaban in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Rivaroxaban in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Rivaroxaban Market Report 2016

1 RIVAROXABAN OVERVIEW

1.1 Product Overview and Scope of Rivaroxaban
1.2 Classification of Rivaroxaban
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Rivaroxaban
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Rivaroxaban Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Rivaroxaban (2011-2021)
  1.5.1 Europe Rivaroxaban Sales and Growth Rate (2011-2021)
  1.5.2 Europe Rivaroxaban Revenue and Growth Rate (2011-2021)

2 EUROPE RIVAROXABAN BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Rivaroxaban Market Competition by Manufacturers
  2.1.1 Europe Rivaroxaban Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Rivaroxaban Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Rivaroxaban (Volume and Value) by Type
  2.2.1 Europe Rivaroxaban Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Rivaroxaban Revenue and Market Share by Type (2011-2016)
2.3 Europe Rivaroxaban (Volume and Value) by Countries
  2.3.1 Europe Rivaroxaban Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Rivaroxaban Revenue and Market Share by Countries (2011-2016)
2.4 Europe Rivaroxaban (Volume) by Application

3 GERMANY RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Rivaroxaban Sales and Value (2011-2016)
  3.1.1 Germany Rivaroxaban Sales and Growth Rate (2011-2016)
  3.1.2 Germany Rivaroxaban Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Rivaroxaban Sales Price Trend (2011-2016)
3.2 Germany Rivaroxaban Sales and Market Share by Manufacturers
3.3 Germany Rivaroxaban Sales and Market Share by Type
3.4 Germany Rivaroxaban Sales and Market Share by Application

4 FRANCE RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

4.1 France Rivaroxaban Sales and Value (2011-2016)
  4.1.1 France Rivaroxaban Sales and Growth Rate (2011-2016)
  4.1.2 France Rivaroxaban Revenue and Growth Rate (2011-2016)
  4.1.4 France Rivaroxaban Sales Price Trend (2011-2016)
4.2 France Rivaroxaban Sales and Market Share by Manufacturers
4.3 France Rivaroxaban Sales and Market Share by Type
4.4 France Rivaroxaban Sales and Market Share by Application

5 UK RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

5.1 UK Rivaroxaban Sales and Value (2011-2016)
  5.1.1 UK Rivaroxaban Sales and Growth Rate (2011-2016)
  5.1.2 UK Rivaroxaban Revenue and Growth Rate (2011-2016)
  5.1.5 UK Rivaroxaban Sales Price Trend (2011-2016)
5.2 UK Rivaroxaban Sales and Market Share by Manufacturers
5.3 UK Rivaroxaban Sales and Market Share by Type
5.4 UK Rivaroxaban Sales and Market Share by Application

6 RUSSIA RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Rivaroxaban Sales and Value (2011-2016)
  6.1.1 Russia Rivaroxaban Sales and Growth Rate (2011-2016)
  6.1.2 Russia Rivaroxaban Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Rivaroxaban Sales Price Trend (2011-2016)
6.2 Russia Rivaroxaban Sales and Market Share by Manufacturers
6.3 Russia Rivaroxaban Sales and Market Share by Type
6.4 Russia Rivaroxaban Sales and Market Share by Application

7 ITALY RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Rivaroxaban Sales and Value (2011-2016)
  7.1.1 Italy Rivaroxaban Sales and Growth Rate (2011-2016)
  7.1.2 Italy Rivaroxaban Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Rivaroxaban Sales Price Trend (2011-2016)
7.2 Italy Rivaroxaban Sales and Market Share by Manufacturers
7.3 Italy Rivaroxaban Sales and Market Share by Type
7.4 Italy Rivaroxaban Sales and Market Share by Application

8 SPAIN RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Rivaroxaban Sales and Value (2011-2016)
  8.1.1 Spain Rivaroxaban Sales and Growth Rate (2011-2016)
  8.1.2 Spain Rivaroxaban Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Rivaroxaban Sales Price Trend (2011-2016)
8.2 Spain Rivaroxaban Sales and Market Share by Manufacturers
8.3 Spain Rivaroxaban Sales and Market Share by Type
8.4 Spain Rivaroxaban Sales and Market Share by Application

9 BENELUX RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Rivaroxaban Sales and Value (2011-2016)
  9.1.1 Benelux Rivaroxaban Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Rivaroxaban Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Rivaroxaban Sales Price Trend (2011-2016)
9.2 Benelux Rivaroxaban Sales and Market Share by Manufacturers
9.3 Benelux Rivaroxaban Sales and Market Share by Type
9.4 Benelux Rivaroxaban Sales and Market Share by Application

10 EUROPE RIVAROXABAN MANUFACTURERS ANALYSIS

10.1 Pfizer, Inc. (US)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Rivaroxaban Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Bayer Healthcare AG (Germany)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Rivaroxaban Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 GlaxoSmithKline Plc. (UK)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Rivaroxaban Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Boehringer Ingelheim (Germany)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Rivaroxaban Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Sanofi S.A. (France)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Rivaroxaban Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Abbott India Limited (India)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Rivaroxaban Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Aspen Holdings (South Africa)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Rivaroxaban Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Bristol-Myers Squibb Company (US)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Rivaroxaban Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Eisai Inc. (US)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Rivaroxaban Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Rivaroxaban Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Teva Pharmaceutical Industries Ltd. (Israel)

11 RIVAROXABAN MANUFACTURING COST ANALYSIS

11.1 Rivaroxaban Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Rivaroxaban

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Rivaroxaban Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE RIVAROXABAN MARKET FORECAST (2016-2021)

14.1 Germany Rivaroxaban Sales Forecast (2016-2021)
14.2 France Rivaroxaban Sales Forecast (2016-2021)
14.3 UK Rivaroxaban Sales Forecast (2016-2021)
14.4 Russia Rivaroxaban Sales Forecast (2016-2021)
14.5 Italy Rivaroxaban Sales Forecast (2016-2021)
14.6 Spain Rivaroxaban Sales Forecast (2016-2021)
14.7 Benelux Rivaroxaban Sales Forecast (2016-2021)
14.8 Europe Rivaroxaban Sales Forecast by Type (2016-2021)
14.9 Europe Rivaroxaban Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Rivaroxaban
Table Classification of Rivaroxaban
Figure Europe Sales Market Share of Rivaroxaban by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Rivaroxaban
Figure Europe Sales Market Share of Rivaroxaban by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure France Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure UK Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Russia Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Italy Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Spain Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Benelux Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Europe Rivaroxaban Sales and Growth Rate (2011-2021)
Figure Europe Rivaroxaban Revenue and Growth Rate (2011-2021)
Table Europe Rivaroxaban Sales of Key Manufacturers (2015 and 2016)
Table Europe Rivaroxaban Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Rivaroxaban Sales Share by Manufacturers
Figure 2016 Rivaroxaban Sales Share by Manufacturers
Table Europe Rivaroxaban Revenue by Manufacturers (2015 and 2016)
Table Europe Rivaroxaban Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Rivaroxaban Revenue Share by Manufacturers
Table 2016 Europe Rivaroxaban Revenue Share by Manufacturers
Table Europe Rivaroxaban Sales and Market Share by Type (2011-2016)
Table Europe Rivaroxaban Sales Share by Type (2011-2016)
Figure Sales Market Share of Rivaroxaban by Type (2011-2016)
Figure Europe Rivaroxaban Sales Growth Rate by Type (2011-2016)
Table Europe Rivaroxaban Revenue and Market Share by Type (2011-2016)
Table Europe Rivaroxaban Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Rivaroxaban by Type (2011-2016)
Figure Europe Rivaroxaban Revenue Growth Rate by Type (2011-2016)
Table Europe Rivaroxaban Sales and Market Share by Countries (2011-2016)
Table Europe Rivaroxaban Sales Share by Countries (2011-2016)
Figure Sales Market Share of Rivaroxaban by Countries (2011-2016)
Table Europe Rivaroxaban Revenue and Market Share by Countries (2011-2016)
Table Europe Rivaroxaban Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Rivaroxaban by Countries (2011-2016)
Table Europe Rivaroxaban Sales and Market Share by Application (2011-2016)
Table Europe Rivaroxaban Sales Share by Application (2011-2016)
Figure Sales Market Share of Rivaroxaban by Application (2011-2016)
Figure Germany Rivaroxaban Sales and Growth Rate (2011-2016)
Figure Germany Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure Germany Rivaroxaban Sales Price Trend (2011-2016)
Table Germany Rivaroxaban Sales by Manufacturers (2015 and 2016)
Table Germany Rivaroxaban Market Share by Manufacturers (2015 and 2016)
Table Germany Rivaroxaban Sales by Type (2015 and 2016)
Table Germany Rivaroxaban Market Share by Type (2015 and 2016)
Table Germany Rivaroxaban Sales by Application (2015 and 2016)
Table Germany Rivaroxaban Market Share by Application (2015 and 2016)
Figure France Rivaroxaban Sales and Growth Rate (2011-2016)
Figure France Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure France Rivaroxaban Sales Price Trend (2011-2016)
Table France Rivaroxaban Sales by Manufacturers (2015 and 2016)
Table France Rivaroxaban Market Share by Manufacturers (2015 and 2016)
Table France Rivaroxaban Sales by Type (2015 and 2016)
Table France Rivaroxaban Market Share by Type (2015 and 2016)
Table France Rivaroxaban Sales by Application (2015 and 2016)
Table France Rivaroxaban Market Share by Application (2015 and 2016)
Figure UK Rivaroxaban Sales and Growth Rate (2011-2016)
Figure UK Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure UK Rivaroxaban Sales Price Trend (2011-2016)
Table UK Rivaroxaban Sales by Manufacturers (2015 and 2016)
Table UK Rivaroxaban Market Share by Manufacturers (2015 and 2016)
Table UK Rivaroxaban Sales by Type (2015 and 2016)
Table UK Rivaroxaban Market Share by Type (2015 and 2016)
Table UK Rivaroxaban Sales by Application (2015 and 2016)
Table UK Rivaroxaban Market Share by Application (2015 and 2016)
Figure Russia Rivaroxaban Sales and Growth Rate (2011-2016)
Figure Russia Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure Russia Rivaroxaban Sales Price Trend (2011-2016)
Table Russia Rivaroxaban Sales by Manufacturers (2015 and 2016)
Table Russia Rivaroxaban Market Share by Manufacturers (2015 and 2016)
Table Russia Rivaroxaban Sales by Type (2015 and 2016)
Table Russia Rivaroxaban Market Share by Type (2015 and 2016)
Table Russia Rivaroxaban Sales by Application (2015 and 2016)
Table Russia Rivaroxaban Market Share by Application (2015 and 2016)
Figure Italy Rivaroxaban Sales and Growth Rate (2011-2016)
Figure Italy Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure Italy Rivaroxaban Sales Price Trend (2011-2016)
Table Italy Rivaroxaban Sales by Manufacturers (2015 and 2016)
Table Italy Rivaroxaban Market Share by Manufacturers (2015 and 2016)
Table Italy Rivaroxaban Sales by Type (2015 and 2016)
Table Italy Rivaroxaban Market Share by Type (2015 and 2016)
Table Italy Rivaroxaban Sales by Application (2015 and 2016)
Table Italy Rivaroxaban Market Share by Application (2015 and 2016)
Figure Spain Rivaroxaban Sales and Growth Rate (2011-2016)
Figure Spain Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure Spain Rivaroxaban Sales Price Trend (2011-2016)
Table Spain Rivaroxaban Sales by Manufacturers (2015 and 2016)
Table Spain Rivaroxaban Market Share by Manufacturers (2015 and 2016)
Table Spain Rivaroxaban Sales by Type (2015 and 2016)
Table Spain Rivaroxaban Market Share by Type (2015 and 2016)
Table Spain Rivaroxaban Sales by Application (2015 and 2016)
Table Spain Rivaroxaban Market Share by Application (2015 and 2016)
Figure Benelux Rivaroxaban Sales and Growth Rate (2011-2016)
Figure Benelux Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure Benelux Rivaroxaban Sales Price Trend (2011-2016)
Table Benelux Rivaroxaban Sales by Manufacturers (2015 and 2016)
Table Benelux Rivaroxaban Market Share by Manufacturers (2015 and 2016)
Table Benelux Rivaroxaban Sales by Type (2015 and 2016)
Table Benelux Rivaroxaban Market Share by Type (2015 and 2016)
Table Benelux Rivaroxaban Sales by Application (2015 and 2016)
Table Benelux Rivaroxaban Market Share by Application (2015 and 2016)
Table Rivaroxaban Basic Information List
Table Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Rivaroxaban Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Rivaroxaban Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Rivaroxaban Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Rivaroxaban Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Rivaroxaban Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivaroxaban
Figure Manufacturing Process Analysis of Rivaroxaban
Figure Rivaroxaban Industrial Chain Analysis
Table Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
Table Major Buyers of Rivaroxaban
Table Distributors/Traders List
Figure Germany Rivaroxaban Sales and Growth Rate Forecast (2016-2021)
Figure Germany Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Figure France Rivaroxaban Sales and Growth Rate Forecast (2016-2021)
Figure France Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Figure UK Rivaroxaban Sales and Growth Rate Forecast (2016-2021)
Figure UK Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Rivaroxaban Sales and Growth Rate Forecast (2016-2021)
Figure Russia Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Rivaroxaban Sales and Growth Rate Forecast (2016-2021)
Figure Italy Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Rivaroxaban Sales and Growth Rate Forecast (2016-2021)
Figure Spain Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Rivaroxaban Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Table Europe Rivaroxaban Sales Forecast by Type (2016-2021)
Table Europe Rivaroxaban Sales Forecast by Application (2016-2021)